Peptide directoryGut, pancreas & liver

Ghrelin

The stomach’s hunger signal, and the one hormone that rises before a meal.

Related medicinesMacimorelinAnamorelin

Where it comes from

Made in
Endocrine cells in the lining of the stomach, mostly the fundus, with less from the small intestine and pancreas
Sent out by
Fasting: levels climb before an expected meal and fall within an hour of eating
Acts on
  • Hypothalamus (NPY and AgRP neurons)
  • Pituitary
  • Vagus nerve
  • Pancreas

What it does

  • Signals hunger and starts meals
  • Releases growth hormone from the pituitary 1
  • Favours fat storage and raises blood glucose

In medicine

  • Macimorelin, an oral ghrelin receptor agonist, is approved to diagnose growth hormone deficiency in adults
  • Anamorelin is approved in Japan for the weight loss of cancer
  • Ghrelin falls in the months after gastric bypass in many studies, though not all; how much it explains the loss of appetite is debated

Beyond the body’s own use

  • The “growth hormone secretagogues” ipamorelin, GHRP-2, GHRP-6 and hexarelin, and the oral MK-677 (ibutamoren), all imitate ghrelin at its receptor, and none is an approved medicine. In 65 healthy older adults given MK-677 for a year, fat-free mass rose by about a kilogram, but fasting glucose rose too and insulin sensitivity fell 2
  • Peptides of this family obtained outside the approved supply are not reviewed for safety, effectiveness or quality, and the whole class is banned in sport at all times 4
  • Anamorelin was refused in Europe in 2017: the regulator found the gain in lean mass small and no improvement in grip strength or in how patients felt 3
  • Ghrelin itself has been infused in studies of appetite in cancer and chronic illness. It lasts minutes in the blood, which is why no infusion has become a treatment 1

Sources

  1. Kojima et al., Ghrelin is a growth-hormone-releasing acylated peptide from stomach, Nature 1999
  2. Nass et al., An oral ghrelin mimetic and body composition in healthy older adults, Annals of Internal Medicine 2008
  3. EMA assessment report, Adlumiz (anamorelin)
  4. World Anti-Doping Agency Prohibited List

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.